Literature DB >> 9808155

Keratinocyte growth arrest is associated with activation of a transcriptional repressor element in the human cdk1 promoter.

A L Dahler1, S J Jones, A J Dicker, N A Saunders.   

Abstract

In this study we examined the regulation of cdk1 expression in normal human epidermal keratinocytes (HEKs) and neoplastic keratinocytes. Keratinocytes were growth-arrested by allowing the cells to grow to confluence or by treating them with interferon-gamma (IFNgamma) or 12-O-tetradecanoyl phorbol-13-acetate (TPA). RT-PCR and Western blot analysis demonstrated that cdk1 was profoundly reduced in growth-arrested HEKs when compared with dividing HEKs. In contrast, a squamous carcinoma cell line, SCC25, did not growth-arrest in response to growth inhibitors and did not downregulate cdk1 expression. Transfection of HEKs with a reporter gene driven off a 2.5-kb fragment of the human cdk1 promoter indicated that the downregulation of cdkl upon growth arrest was transcriptional. Deletion mapping of the cdk1 promoter indicated that a repressor region was located between -949 - -722 bp. This repressor region was not operative in the SCC25 cells. Examination of DNA:protein binding complexes by gel-shift analysis indicated that nuclear factors from both proliferative and growth-arrested cells bound to the DNA fragment spanning -949- -722 bp. Further analysis revealed that this binding could be resolved into a constitutive and growth arrest-specific complex that bound in a similar fashion to regions spanning -892 - -831 bp and -831 - -774 bp, respectively. The putative growth arrest-specific complex was not found in contact-inhibited fibroblasts and was found at very low levels in SCC25 cells, indicating that the putative repressor binding was growth arrest-specific and possibly keratinocyte-specific. The binding complexes bound to these two fragments were localized, by competition analysis, to regions -874 - -853 bp and -830 - -800 bp. This is the first report of a transcriptional repressor being operative during keratinocyte growth arrest.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808155     DOI: 10.1002/(SICI)1097-4652(199812)177:3<474::AID-JCP10>3.0.CO;2-M

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  Confluence-Induced Squamous Differentiation Is Not Accompanied by Changes in H3K27me3 Repressive Epigenetic Mark.

Authors:  Orla M Gannon; Lilia Merida de Long; Mehlika Hazar-Rethinam; Eleni Topkas; Liliana B Endo-Munoz; Gethin P Thomas; Ping Zhang; Nicholas A Saunders
Journal:  J Invest Dermatol       Date:  2015-05-04       Impact factor: 8.551

2.  Folic acid supplementation increases survival and modulates high risk HPV-induced phenotypes in oral squamous cell carcinoma cells and correlates with p53 mRNA transcriptional down-regulation.

Authors:  Michael Moody; Oanh Le; Megan Rickert; Jeremy Manuele; Sarah Chang; Gary Robinson; Jeffrey Hajibandeh; John Silvaroli; Mark A Keiserman; Christine J Bergman; Karl Kingsley
Journal:  Cancer Cell Int       Date:  2012-03-23       Impact factor: 5.722

3.  PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.

Authors:  Fei-Ran Gong; Meng-Yao Wu; Meng Shen; Qiaoming Zhi; Ze-Kuan Xu; Rong Wang; Wen-Jie Wang; Yang Zong; Zeng-Liang Li; Yadi Wu; Binhua P Zhou; Kai Chen; Min Tao; Wei Li
Journal:  Oncotarget       Date:  2015-07-30

4.  The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.

Authors:  Ashraf Khalil; Mark J Jameson
Journal:  Drugs R D       Date:  2017-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.